Marika Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Marika Inc
TickerPVLA
CIK #0001583648
CUSIP697947109
SectorTrade & Services - Services-Business Services, Nec
Address2360 Corporate Circle Suite 400, Henderson, NV 89074
Source [EDGAR]
CIK Filing 2011 - 2025
[0001583648] 10-K
[0001583648] 10-Q
[0001583648] 3
[0001583648] 4
[0001583648] 8-K
[0001583648] D
[0001583648] SC 13D
[0001583648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08] 0.0
Kaupinen WES Palvella Therapeutics Inc [2024-12-20] 0.0
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20] 0.0
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20] 0.0
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07] 0.0
Adar1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01] 10.5
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12] 6.0
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2023-05-22] 11.8
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2023-01-27] 5.4
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24] 5.1
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2022-01-27] 5.4
Citadel Advisors LLC Pieris Pharmaceuticals Inc [2021-07-06] 4.9
Astrazeneca PLC Pieris Pharmaceuticals Inc [2021-04-08] 5.66
Seagen Inc Pieris Pharmaceuticals Inc [2021-04-02] 6.2
Nussbaum Ran Pieris Pharmaceuticals Inc [2021-02-16] 6.4
BlackRock Inc Pieris Pharmaceuticals Inc [2020-02-07] 6.2
EcoR1 Capital LLC Pieris Pharmaceuticals Inc [2019-11-14] 8.8
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07] 5.1
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2016-06-17] 4.1
Lombard Odier Asset Management USA Corp Pieris Pharmaceuticals Inc [2016-02-16] 7.17
Tekla Capital Management LLC Pieris Pharmaceuticals Inc [2016-02-12] 0.7
Novo Nordisk A S Pieris Pharmaceuticals Inc [2016-01-28] 5.2
Global Life Bioventure IV SARL Pieris Pharmaceuticals Inc [2015-09-11] 6.25
Tompkins Mark N Pieris Pharmaceuticals Inc [2015-07-10] 5.6
OrbiMed Advisors LLC Pieris Pharmaceuticals Inc [2015-07-09] 18.8
Form 3/4/5 Filer 2011 - 2025
Wessel Tadd S.
Palvella Therapeutics Inc
Davis Todd C
Heron Elaine J
Jenkins George M
Kiritsy Christopher P
Kline Ashley Hartmann
Martini Jeffrey S
Goin Kathleen
Korenberg Matthew E
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Kaupinen Wes
Dellora Investments LP
Geraghty James A
ADAR1 Capital Management, LLC
ADAR1 Partners, LP
Richman Michael
Said Maya R.
Barbier Ann
Sherman Matthew L
Kiener Peter A
Yoder Stephen S.
Olwill Shane
Mousa Ahmed
Kaufmann Hitto
Bures Thomas
Demuth Tim
Aquilo Capital Management, LLC
Bizzari Jean-Pierre
Reine Allan
Matis Louis
Prelack Steven
OrbiMed Capital GP III LLC
OrbiMed Advisors LLC
Adams Julian
Isaly Samuel D
Khuong Chau Quang
Thibault Lance E
Knopf Claude
Deptula-Hicks Darlene M
Takke Christina
Form 13F Holdings
Firm Period DFND Voting Shares
Frazier Life Sciences Management LP [2025-06-30] SOLE 722,400 722,400
Suvretta Capital Management LLC [2025-06-30] SOLE 714,463 714,463
BVF Inc/IL [2025-06-30] DFND 0 696,555
Woodline Partners LP [2025-06-30] SOLE 445,615 445,615
BlackRock, Inc. [2025-06-30] SOLE 438,791 445,052
Samsara Biocapital LLC [2025-06-30] SOLE 339,743 339,743
Millennium Management LLC [2025-06-30] SOLE 314,989 314,989
Adams Street Partners LLC [2025-06-30] SOLE 298,986 298,986
Nantahala Capital Management LLC [2025-06-30] SOLE 250,062 250,062
Geode Capital Management LLC [2025-06-30] DFND 173,986 173,986
Vanguard Group Inc [2025-06-30] SOLE 0 153,476
Morgan Stanley [2025-06-30] DFND 28,950 135,754
Blue Owl Capital Holdings LP [2025-06-30] DFND 0 125,259
Sectoral Asset Management Inc [2025-06-30] SOLE 0 95,615
CLIO Asset Management LLC [2025-06-30] SOLE 0 91,508
Goldman Sachs Group Inc [2025-06-30] DFND 85,329 85,329
State Street Corp [2025-06-30] DFND 75,027 82,011
Royce & Associates LP [2025-06-30] SOLE 74,516 74,516
AWM Investment Company Inc [2025-06-30] SOLE 69,416 69,416
Renaissance Technologies LLC [2025-06-30] SOLE 66,858 66,858
J Goldman & Co LP [2025-06-30] SOLE 56,290 56,290
Northern Trust Corp [2025-06-30] DFND 53,453 53,453
Marshall Wace LLP [2025-06-30] OTR 0 49,077
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM [2025-06-30] DFND 43,994 43,994
DAFNA Capital Management LLC [2025-06-30] SOLE 43,348 43,348
UBS Group AG [2025-06-30] DFND 43,149 43,149
Susquehanna International Group LLP [2025-06-30] OTR 17,384 27,284
Charles Schwab Investment Management Inc [2025-06-30] SOLE 21,013 21,013
Cresset Asset Management LLC [2025-06-30] SOLE 20,911 20,911
Strid Group LLC [2025-06-30] SOLE 0 18,166
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com